Announced on | Meeting on |
Apr 26, 2024 | May 13, 2024 |
Quarterly Results | |
Jan 24, 2024 | Feb 23, 2024 |
Audited Results & Dividend | |
Oct 19, 2023 | Nov 08, 2023 |
Quarterly Results | |
Jul 26, 2023 | Aug 10, 2023 |
Quarterly Results | |
Apr 11, 2023 | May 10, 2023 |
Quarterly Results |
Sanofi India Share Price
- Open6,614.00
- High6,624.00
- Low6,511.10
- Prev Close6,500.00
- Volume3,228
- VWAP(₹)6,561.87
Sanofi India share price insights
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 13.0% towards employee cost in the year ending 31 Dec, 2023. (Source: Consolidated Financials)Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of -15.77% as compared to Nifty Midcap 100 which gave a return of 98.13%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -15.77% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)Sanofi India Share Price Update
Sanofi India Ltd. share price moved up by 0.74% from its previous close of Rs 6,500.00. Sanofi India Ltd. stock last traded price is 6,548.00
Share Price Value Today/Current/Last 6,548.00 Previous Day 6,500.00
Sanofi India Share Price Returns
1 Day | 0.74% |
1 Month | -24.1% |
3 Months | -19.25% |
1 Year | -5.27% |
3 Years | -14.53% |
5 Years | 14.35% |
Key Metrics
PE Ratio(x) | 27.26 |
EPS - TTM(₹) | 238.44 |
MCap(₹ Cr.) | 14,969.90 |
MCap Rank | 29 |
PB Ratio(x) | 14.75 |
Div Yield(%) | 2.57 |
Face Value(₹) | 10.00 |
52W High(₹) | 10,524.95 |
52W Low(₹) | 5,892.80 |
MCap/Sales | 6.51 |
Beta(1 Month) | 0.46 |
BV/Share(₹) | 440.80 |
Sanofi India Share Recommendations
3 Analysts
SellSellHoldBuyStrong
Buy
Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 1 |
Hold | - | - | - | 1 |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 3 | 3 | 3 | 3 |
Sanofi India News & Analysis
Sanofi India Financials
Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 738.90 705.90 726.40 721.80 Total Income Growth (%) 4.67 -2.82 0.64 -5.31 Total Expenses 550.20 516.70 516.20 537.70 Total Expenses Growth (%) 6.48 0.10 -4.00 7.86 EBIT 188.70 189.20 210.20 184.10 EBIT Growth (%) -0.26 -9.99 14.18 -30.21 Profit after Tax (PAT) 136.60 137.70 151.95 122.90 PAT Growth (%) -0.80 -9.38 23.63 -35.45 EBIT Margin (%) 25.54 26.80 28.94 25.51 Net Profit Margin (%) 18.49 19.51 20.92 17.03 Basic EPS (₹) 59.31 59.79 65.95 53.37 All figures in Rs Cr, unless mentioned otherwise
InsightsEmployee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 13.0% towards employee cost in the year ending 31 Dec, 2023. (Source: Consolidated Financials)
Annual FY 2023 Total Assets 1,714.80 Total Assets Growth (%) - Total Liabilities 699.60 Total Liabilities Growth (%) - Total Equity 1,015.20 Total Equity Growth (%) - Current Ratio (x) 1.92 Total Debt to Equity (x) 0.00 Contingent Liabilities 297.10 All figures in Rs Cr, unless mentioned otherwise
InsightsZero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)
Annual FY 2023 Net Cash flow from Operating Activities 230.40 Net Cash used in Investing Activities 37.50 Net Cash flow from Financing Activities -878.30 Net Cash Flow -610.40 Closing Cash & Cash Equivalent 394.50 Closing Cash & Cash Equivalent Growth (%) - Total Debt/ CFO (x) 0.00 All figures in Rs Cr, unless mentioned otherwise
InsightsCash from Operations vs PAT
Operating cash flow of Rs 230.4 cr is 0.38 times compared to the reported net profit of Rs 602.9 cr. (Source: Consolidated Financials)
Annual FY 2023 Return on Equity (%) 59.38 Return on Capital Employed (%) 77.98 Return on Assets (%) 35.15 Interest Coverage Ratio (x) 511.18 Asset Turnover Ratio (x) - Price to Earnings (x) 30.86 Price to Book (x) 18.28 EV/EBITDA (x) 20.88 EBITDA Margin (%) 30.47 InsightsROE Outperforming 5 Year Average
Company delivered ROE of 59.39% in year ending 31 Dec, 2023 outperforming its 5 year avg. of 33.71%. (Source: Standalone Financials)
Peer Comparison
NAME 1D 1W 1M 3M 1Y 3Y 5Y Sanofi India Stock Performance -1.70 -23.80 -18.83 -22.38 -5.75 -15.05 20.94 Abbott India Stock Performance 0.91 6.71 8.07 0.69 26.77 71.82 246.80 GSK Pharma Stock Performance -1.00 1.21 34.17 29.32 94.08 78.86 107.64 Pfizer Stock Performance 0.08 -1.76 5.20 0.03 14.66 -15.88 43.07 AstraZeneca Stock Performance -2.03 1.16 21.78 15.26 79.70 65.51 236.38 All values in %
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of -15.77% as compared to Nifty Midcap 100 which gave a return of 98.13%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -15.77% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
Mutual Funds Ownership
MF Ownership as on 31 May 2024
238.16
Amount Invested (in Cr.)
0.87%
% of AUM
0.00
% Change (MoM basis)
203.61
Amount Invested (in Cr.)
2.84%
% of AUM
0.00
% Change (MoM basis)
195.64
Amount Invested (in Cr.)
0.7%
% of AUM
0.00
% Change (MoM basis)
Corporate Actions
Board Meeting
Quarterly Results
Apr 26, 2024
Final
1170%
Feb 24, 2024
Interim Dividend
500%
Feb 23, 2024
Announced on Ex-Date Dividend% Feb 24, 2024 May 03, 2024 1170% Feb 23, 2024 Mar 07, 2024 500% Feb 24, 2023 Apr 28, 2023 1830% Feb 23, 2023 Apr 28, 2023 1940% Jul 13, 2022 Aug 05, 2022 1930% Announced on Ex-Date Aug 31, 1994 Sep 23, 1994 Bonus Ratio: 1 share(s) for every 1 shares held Announced on Ex-Date Jan 03, 1996 Nov 18, 1991 Split: Old FV100.0| New FV:10.0 No Data Available
Announced on Meeting on Jan 12, 2024 Feb 15, 2024 - Nov 13, 2023 Dec 18, 2023 - Oct 03, 2023 Nov 07, 2023 - Feb 23, 2023 May 11, 2023 Book closure from 29 Apr, 2023 to 11 May, 2023 Apr 28, 2022 Jun 17, 2022 -
About
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 14,969.90 Crore) operating in Pharmaceuticals sector.
Sanofi India Ltd. key Products/Revenue Segments include Pharmaceutical Products, Sale of services, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Dec-2023.
For the quarter ended 31-03-2024, the company has reported a Consolidated Total Income of Rs 738.90 Crore, up 4.67 % from last quarter Total Income of Rs 705.90 Crore and down 3.07 % from last year same quarter Total Income of Rs 762.30 Crore. Company has reported net profit after tax of Rs 136.60 Crore in latest quarter.
The company’s top management includes Mr.Aditya Narayan, Mr.Rodolfo Hrosz, Mr.Rachid Ayari, Ms.Renee Amonkar, Mr.Vaibhav Karandikar, Mr.Rahul Bhatnagar, Mrs.Usha Thorat, Ms.Radhika Shah. Company has Price Waterhouse & Co Chartered Accountants LLP as its auditors. As on 31-03-2024, the company has a total of 2.30 Crore shares outstanding.
About Sanofi India
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 14,969.90 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments include Pharmaceutical Products, Sale of services, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Dec-2023.For the quarter ended 31-03-2024, the company has reported a Consolidated Total Income of Rs 738.90 Crore, up 4.67 % from last quarter Total Income of Rs 705.90 Crore and down 3.07 % from last year same quarter Total Income of Rs 762.30 Crore. Company has reported net profit after tax of Rs 136.60 Crore in latest quarter.The company’s top management includes Mr.Aditya Narayan, Mr.Rodolfo Hrosz, Mr.Rachid Ayari, Ms.Renee Amonkar, Mr.Vaibhav Karandikar, Mr.Rahul Bhatnagar, Mrs.Usha Thorat, Ms.Radhika Shah. Company has Price Waterhouse & Co Chartered Accountants LLP as its auditors. As on 31-03-2024, the company has a total of 2.30 Crore shares outstanding.
Industry
Key Indices Listed On
Nifty 500, Nifty Pharma, NIFTY 500 Multicap 50:25:25 Index, Nifty MidSmall Healthcare, Nifty MidSmallcap 400
Address
Sanofi House,CTS No. 117-B,Mumbai, Maharashtra - 400072
Executive Leadership
Aditya Narayan
Chairman & Ind.DirectorRodolfo Hrosz
Managing DirectorRachid Ayari
WholeTime Director & CFORenee Amonkar
Whole Time DirectorAuditors
FAQs about Sanofi India share
- 1. What's the Sanofi India share price today?Sanofi India share price was Rs 6,548.00 as on 01 Jul, 2024, 09:48 AM IST. Sanofi India share price was up by 0.74% based on previous share price of Rs. 10051.5. In last 1 Month, Sanofi India share price moved down by 24.10%.
- 2. What is the market cap of Sanofi India?Within the Pharmaceuticals sector, Sanofi India stock has a market cap rank of 29. Sanofi India has a market cap of Rs 14,969.90 Cr.
- 3. What are the returns for Sanofi India share?Return Performance of Sanofi India Shares:
- 1 Week: Sanofi India share price moved down by 3.70%
- 1 Month: Sanofi India share price moved down by 24.10%
- 3 Month: Sanofi India share price moved down by 19.25%
- 6 Month: Sanofi India share price moved down by 19.40%
- 4. Is Sanofi India giving dividend?An equity Final dividend of Rs 117 per share was declared by Sanofi India Ltd. on 24 Feb 2024. So, company has declared a dividend of 1170% on face value of Rs 10 per share. The ex dividend date was 03 May 2024.
- 5. What are the key metrics to analyse Sanofi India Share Price?Key Metrics for Sanofi India are:
- Price to Book ratio of Sanofi India is 14.75
- 6. What is Sanofi India's 52 week high / low?In last 52 weeks Sanofi India share had a high price of Rs 10,524.95 and low price of Rs 5,892.80
- 7. What are the Sanofi India quarterly results?On Consoldiated basis, Sanofi India reported a total income and profit of Rs 738.90 Cr and Rs 136.60 respectively for quarter ending 2024-03-31. Total Income and profit for the year ending 2023-12-31 was Rs 2916.40 Cr and Rs 602.90 Cr.
- 8. Which are the key peers to Sanofi India?Within Pharmaceuticals sector Sanofi India, AstraZeneca Pharma India Ltd., Pfizer Ltd., Procter & Gamble Health Ltd., Novartis India Ltd., GlaxoSmithKline Pharmaceuticals Ltd. and Abbott India Ltd. are usually compared together by investors for analysis.
- 9. Who are the key owners of Sanofi India stock?Promoter,DII and FII owns 60.4, 20.83 and 6.31 shares of Sanofi India as on 31 Mar 2024
- There is no change in promoter holding from 31 Dec 2023 to 31 Mar 2024
- Domestic Institutional Investors holding has gone up from 20.83 (31 Dec 2023) to 22.88 (31 Mar 2024)
- Foreign Institutional Investors holding have gone down from 6.31 (31 Dec 2023) to 6.11 (31 Mar 2024)
- Other investor holding have gone down from 12.46 (31 Dec 2023) to 10.61 (31 Mar 2024)
- 10. Who's the chairman of Sanofi India?Aditya Narayan is the Chairman & Ind.Director of Sanofi India
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.